secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001493152-22-035728
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma to use Nexcella slide presentation in investor meetings; no specifics given
--------------------------------------------------------------------------------

- Slide presentation of wholly-owned subsidiary Nexcella to be used in third-party meetings.
- No financial or operational details from the presentation are included in the filing.
- Event is a routine FD disclosure; no substantive news provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315222035728/0001493152-22-035728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315222035728/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-035728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer